Compare SGHT & BLND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SGHT | BLND |
|---|---|---|
| Founded | 2011 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 309.6M | 364.2M |
| IPO Year | 2021 | 2021 |
| Metric | SGHT | BLND |
|---|---|---|
| Price | $8.16 | $1.44 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 6 |
| Target Price | ★ $9.08 | $4.13 |
| AVG Volume (30 Days) | 206.2K | ★ 1.9M |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 28.16 | ★ 58.33 |
| EPS | N/A | ★ N/A |
| Revenue | $77,363,000.00 | ★ $123,585,000.00 |
| Revenue This Year | $11.67 | $12.62 |
| Revenue Next Year | $10.39 | $14.00 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.19 | $1.18 |
| 52 Week High | $9.24 | $4.49 |
| Indicator | SGHT | BLND |
|---|---|---|
| Relative Strength Index (RSI) | 56.69 | 40.98 |
| Support Level | $8.00 | $1.35 |
| Resistance Level | $8.80 | $1.60 |
| Average True Range (ATR) | 0.35 | 0.07 |
| MACD | -0.15 | 0.00 |
| Stochastic Oscillator | 29.36 | 20.00 |
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.
Blend Labs Inc is a cloud-based platform software platform that powers the digital interface between financial services firms and consumers. It supports and simplifies applications for mortgages, consumer loans, and deposit accounts. Its operating segment is Blend Platform segment which comprises a suite of products that power the entire origination process from back-end workflows to consumer experience. The key revenue for the company is generated from the Blend Platform segment. Company has it's assets in united states, India and Mexico regions.